Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Caldwell Partners Swings To Q2 Loss

Executive search consultancy Caldwell Partners International Inc. (CWL.TO: Quote) Thursday said it swung to a second quarter loss of C$241 thousand or C$0.014 per share from a profit of C$141.6 thousand or C$0.008 per share last year, due mainly to lower revenues.

Net revenues for the period declined 5 percent to C$7.2 million from C$8.8 million last year. The decrease reflects a weakness in Canadian search revenues which more than offset 12 percent growth in US search revenues.

Click here to receive FREE breaking news email alerts for Caldwell Partners International Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Defense forces of the United States and Arab partner nations have begun airstrikes inside Syria targeting terrorists from the Islamic State of Iraq and the Levant, the Pentagon announced on Tuesday. The nations fighting alongside the US include the United Arab Emirates, Bahrain, Jordan, Qatar and Saudi Arabia, which has a Sunni majority. Overnight, a mix of fighters, bombers, remotely piloted ai Yeast bloodstream infections, which are caused by Candida species, are a type of fungal infection, and if untreated, can result in serious medical complications. People who have a weak immune system, or are hospitalized in intensive care units, or have kidney disease needing dialysis, or have had abdominal surgery are said to be at risk of developing yeast bloodstream infections. After moving mostly higher over the course of the previous week, stocks showed a notable move back to the downside during trading on Monday. With the drop on the day, the Dow pulled back well off last Friday's record closing high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.